The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
We expect the global exoskeleton system market to exhibit a CAGR of 43.3% during 2021-2026.
Sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across several nations resulting in disrupted supply chains and temporary closure of numerous manufacturing units for exoskeleton systems.
The growing need for exoskeletons in the rehabilitation centers, along with rising prevalence of heart strokes, spinal cord injuries, paralysis, etc., represent some of the factors catalyzing the global exoskeleton market.
Based on the component, the global exoskeleton system market has been segmented into hardware and software, where hardware currently holds the majority of the total market share.
Based on type, the global exoskeleton system market can be bifurcated into powered exoskeleton and passive exoskeleton. Currently, powered type dominates the market share.
Based on the end use sector, the global exoskeleton system market has been divided into healthcare, defense, industrial, and others. Among these, the healthcare sector accounts for the majority of the total market share.
Based on the mobility, the global exoskeleton system market can be categorized into stationary and mobile. Currently, mobile holds the largest market share.
Some of the major players in the global exoskeleton system market include Bionik Laboratories, Suitx, Gogoa Mobility Solutions, Exhauss, Atoun, Fourier Intelligence, Honda Motor, Daiya Industry Company, Mitsubishi Heavy Industries, Rex Bionics, Myomo, Gobio Robot, Parker Hannifin, Wandercraft, P&S Mechanics, etc.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, where North America currently dominates the global market.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at